For instance, cyclophosphamide (CPA) metronomic therapy has been shown to activate antitumour CD8+ T-cell response, and also induce specific long-term T-cell tumour memory in GL261 GBM tumours growing subcutaneously in immunocompetent mice [30]. This evidence concerns the gene CD8A and neoplasm.